CIGOLINI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 1.401
EU - Europa 1.079
AS - Asia 295
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 2.783
Nazione #
US - Stati Uniti d'America 1.395
GB - Regno Unito 496
CN - Cina 286
SE - Svezia 129
IT - Italia 103
FR - Francia 88
FI - Finlandia 74
IE - Irlanda 74
DE - Germania 57
UA - Ucraina 37
BE - Belgio 12
CA - Canada 6
IL - Israele 4
BR - Brasile 3
RO - Romania 3
RU - Federazione Russa 3
CL - Cile 2
EU - Europa 2
IN - India 2
TR - Turchia 2
EG - Egitto 1
ES - Italia 1
IR - Iran 1
NL - Olanda 1
PT - Portogallo 1
Totale 2.783
Città #
Southend 442
Jacksonville 314
Chandler 253
Woodbridge 160
Ann Arbor 123
Ashburn 75
Dublin 74
Houston 71
Lawrence 39
Princeton 39
Wilmington 38
Beijing 34
Jinan 30
Nanjing 30
New York 28
Shenyang 25
Hebei 21
Washington 19
Lancaster 18
Sindelfingen 14
Milan 13
Nanchang 13
Norwalk 13
Brussels 12
Changsha 12
Hangzhou 12
Zhengzhou 12
Haikou 11
Jiaxing 11
Taiyuan 11
Taizhou 10
Tianjin 10
Verona 10
Boardman 9
Ningbo 9
Falls Church 7
Helsinki 7
Detroit 6
Guangzhou 6
Philadelphia 6
Rome 6
Toronto 6
Bologna 5
Auburn Hills 4
Grammichele 4
Redmond 4
Redwood City 4
Chicago 3
Fuzhou 3
Lanzhou 3
Seattle 3
Caldogno 2
Dearborn 2
Fairfield 2
London 2
Los Angeles 2
Munich 2
Rio de Janeiro 2
San Francisco 2
Satu Mare 2
Tappahannock 2
Aberdeen 1
Adrano 1
Andover 1
Avola 1
Biella 1
Cairo 1
Cambridge 1
Castel San Giorgio 1
Cerano 1
Chengdu 1
Chions 1
Civitanova Marche 1
Clearwater 1
Dalian 1
Duncan 1
Ferentino 1
Groningen 1
Jeffries 1
Kemerovo 1
Lappeenranta 1
Leawood 1
Lomazzo 1
Melissano 1
Novello 1
Paderno 1
Pesaro 1
Pordenone 1
Qingdao 1
Reggio Nell'emilia 1
Riva 1
San Giorgio del Sannio 1
San Mateo 1
Santa Giustina 1
Scafati 1
Sigillo 1
Somma Lombardo 1
Spoltore 1
Stezzano 1
Stockholm 1
Totale 2.151
Nome #
Misurazione della sensibilità insulinica in vivo con il test all'insulina e.v. (I.T.T.). Confronto con il clamp iperglicemico in un gruppo di soggetti normali. 137
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 116
Liver steatosis and its relation to plasma haemostatic factors in apparently healthy males. Role of the metabolic syndrome. 103
Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies 100
Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables. 99
Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women 98
Hyperuricaemia: relationships to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women 94
Differences in glucose metabolic enzyme activities in human adipose tissue from abdominal and gluteal regions 93
The white blood cell count:its relatioship to plasma insulin and other cardiovascular risk factors in healthy male 91
Enzimi nel metabolismo glucidico nell'obesità e nel diabete. 90
Livelli plasmatici di C-peptide e glucagone in soggetti obesi durante clamp iperglicemico con e senza infusione di somatostatina. 87
Glucose and insulin suppression of plasma free fatty acids in obese subjects with normal glucose tolerance or mild, newly diagnosed type 2 (non-insulin-dependent) diabetes 84
Influenza della metformina su alcune alterazioni del metabolismo glucidico indotte dalla restrizione calorica nel tessuto adiposo umano 79
Attività di esochinasi, glucosio-6-P-gluconato deidrogenasi, fosfofruttochinasi nel tessuto adiposo gluteo e addominale dell'obeso:effetto del semidigiuno. 79
Ultrasonographic intra-abdominal depth and its relation to haemostatic factors in healthy males 77
Interrelazioni tra acidi grassi di deposito in tessuto adiposo sottocutaneo, assetto lipidico ed attività fibrinolitica plasmatica. 77
Inflammatory markers may mediate the link between low plasma vitamin B6 concentrations and cardiovascular disease in type 2 diabetes. 76
Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men. The European Fat Distribution Study. 74
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 74
Hypovitaminosis D among unselected in-patients and out-patients in northern Italy. 70
Normale effetto inibitorio della somatostatina sulla secrezione della cellula B pancreatica nell'obesità umana 70
Plasma free fatty acid concentration during hyperglycemic glucose clamp with and without somatostatin infusion in obese subjects with normal glucose tolerance 67
Liver steatosis and its relation to plasma haemostatic factors in apparently healthy males. Role of the metabolic syndrome. 67
Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. 64
Plasma factor VII and its relation to adipose tissue fatty acids and other atherogenic risk factors in healthy men. 64
Enzymatic activities related to intermediary metabolism of glucose in circulating mononuclear cells from obese humans: relationship to enzyme activity in adipose tissue 62
Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men. 62
Normal inhibition by somatostatin of glucose-stimulated B cell secretion in the obese subjects 61
Plasma fibrinogen in relation to serum insulin, smoking habits and adipose tissue fatty acids in healthy men. 61
Serum Lp(a) levels in randomized healthy men from different European countries. 57
Studio comparativo dell'attività di alcuni enzimi del metabolismo glucidico nelle cellule mononucleate circolanti e nel tessuto adiposo. 51
DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives 51
Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. 47
Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients 41
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes-The TOSCA.IT Study 41
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study 39
Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. 35
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 35
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 27
Totale 2.800
Categoria #
all - tutte 7.906
article - articoli 6.348
book - libri 0
conference - conferenze 1.362
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 196
Totale 15.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 1 2 3
2019/2020412 43 16 5 33 40 48 45 39 7 42 30 64
2020/2021382 36 44 9 39 46 52 8 36 46 19 33 14
2021/2022380 48 94 4 28 17 36 8 19 17 12 28 69
2022/2023656 49 76 57 168 57 130 5 37 52 4 20 1
2023/2024193 11 28 22 28 29 60 8 5 2 0 0 0
Totale 2.800